The results with a p < 0.05 was considered statistically significant and p < 0.01 was considered highly significant.
← all excerpts
Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
1
—
—